Prescribing patterns and the use of therapeutic drug monitoring of psychotropic medication in a psychiatric high-security unit

Therapeutic Drug Monitoring
Ingrid Castberg, Olav Spigset

Abstract

The aim of this study was to investigate the use of psychotropic medication and therapeutic drug monitoring in a high-security psychiatric unit and to compare the doses and serum concentrations both with the recommended intervals and with the doses and serum concentrations in a control group. One hundred thirty-two patients were admitted in the period from January 2000 to December 2005. All available samples were used when comparing serum concentrations and doses with the recommended ranges. For the comparison of doses and serum concentration-to-dose (C:D) ratios with the control group only 1 sample from each patient was used. A total of 459 analyses of 27 different drugs in samples from 8 women and 73 men were included. The median number of therapeutic drug monitoring analyses per patient was 4 (range 1-29). Thirty-seven of the 81 patients (46%) used 2 or more antipsychotics at the same time. Clozapine, lamotrigine, olanzapine, quetiapine, ziprasidone, and zuclopenthixol were often given in doses above the recommended. The serum levels were frequently above those recommended for clozapine, olanzapine, quetiapine, risperidone, ziprasidone, and zuclopenthixol. The serum levels were significantly higher in the study group than in...Continue Reading

References

Aug 1, 1995·Journal of Clinical Psychopharmacology·P CzoborR C Meibach
Oct 6, 2000·Clinical Pharmacokinetics·G Cheymol
Aug 21, 2001·Clinical Pharmacokinetics·C L DeVane, C B Nemeroff
Oct 31, 2001·Psychiatric Services : a Journal of the American Psychiatric Association·L CitromeJ A Lieberman
Mar 27, 2003·Therapeutic Drug Monitoring·John F Wilson
Jun 5, 2003·Psychiatric Genetics·Eiji SuzukiToshiya Inada
Oct 7, 2003·International Journal of Offender Therapy and Comparative Criminology·Candace WalkerTimothy S Allen
Jul 2, 2004·Therapeutic Drug Monitoring·Finn Bengtsson
Jul 17, 2004·British Journal of Clinical Pharmacology·Bruce Green, Stephen B Duffull
Nov 17, 2004·Pharmacopsychiatry·B BaumannH Bielau
Nov 20, 2004·Pharmacopsychiatry·P BaumannUNKNOWN Arbeitsge-meinschaft fur neuropsychopharmakologie und pharmakopsychiatrie
Feb 25, 2005·Experimental and Clinical Psychopharmacology·Matthew S StanfordRebecca J Houston
Jul 14, 2005·Journal of Clinical Psychopharmacology·Arne ReimersOlav Spigset
Jul 26, 2005·Journal of Psychiatric Practice·Vijayalakshmy PatrickSteven Schleifer
Dec 20, 2005·European Psychiatry : the Journal of the Association of European Psychiatrists·C ArangoJ Bobes
Apr 26, 2006·Nordic Journal of Psychiatry·Sabine Renkel, Kirsten Rasmussen
May 4, 2006·The Journal of Clinical Psychiatry·Leslie CitromeFrancine S Mandel
Jun 7, 2006·Archives of General Psychiatry·Menahem I KrakowskiThomas B Cooper
Jul 21, 2006·Journal of Clinical Psychopharmacology·Julia KirchheinerJurgen Gallinat
Sep 16, 2006·Journal of Clinical Psychopharmacology·Gabriella GobbiNancy Leblanc
Nov 8, 2006·European Journal of Clinical Pharmacology·Tore HaslemoHelge Refsum
May 2, 2007·The British Journal of Psychiatry : the Journal of Mental Science·Frank HaesslerUNKNOWN Zuclopenthixol Disruptive Behaviour Study Group
Oct 24, 2007·Clinical Pharmacology and Therapeutics·P Y HanB Green
Oct 27, 2007·The Journal of Clinical Psychiatry·Ingrid CastbergOlav Spigset

❮ Previous
Next ❯

Citations

Dec 8, 2011·Journal of Palliative Medicine·Nadia Mohamad RashidiJennifer A M Philip
Oct 13, 2009·Current Opinion in Psychiatry·Torleif Ruud
Aug 30, 2012·The Psychiatric Clinics of North America·Christoph U Correll, Juan A Gallego
Dec 11, 2013·Journal of Analytical Toxicology·Kristian Linnet, Sys Stybe Johansen
May 16, 2013·The International Journal of Neuropsychopharmacology·Nitin TotejaChristoph U Correll
Dec 24, 2014·Social Science & Medicine·Dominique P Béhague
Nov 3, 2010·The Australian and New Zealand Journal of Psychiatry·Gennady N BaksheevJames R P Ogloff
Apr 27, 2012·The Australian and New Zealand Journal of Psychiatry·Elise V GriffithsM Joy Spark
Apr 26, 2013·Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists·David CastleJohn Tiller
Jul 14, 2010·Pharmacoepidemiology and Drug Safety·Gillian E CaugheyAndrew L Gilbert
Jul 28, 2009·Australian and New Zealand Journal of Public Health·Stuart A KinnerLouisa Degenhardt
Apr 8, 2014·Expert Review of Neurotherapeutics·Andrea NegroPaolo Martelletti
Jun 27, 2014·Neurochemical Research·Aron D MosnaimMarion E Wolf
Nov 15, 2019·Nordic Journal of Psychiatry·Hanne HøilundPetter Andreas Ringen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here